FDA Warns About Adverse Events in Conjunction With 2 LVADs
Two FDA-approved implantable left ventricular assist devices have been linked to a series of serious adverse events and complications, including stroke and bleeding.
Interventional
No Perioperative Benefit, Higher Bleeding Risk with Bridging Anticoagulation
Perioperative anticoagulation bridging may not improve outcomes in patients with atrial fibrillation who also take warfarin.
Better Long-Term Survival with Less Invasive Abdominal Aortic Aneurysm Repair
Endovascular aneurysm repair shows greater survival rates than open surgery at 3-year follow-up.
PRESERVATION I Trial Shows No Benefit for Bioabsorbable Cardiac Matrix Treatment in Patients With Myocardial Infarction
Researchers found no benefit in using Bioabsorbable Cardiac Matrix treatment in patients who sustained a heart attack when compared with a saline placebo.
No Benefit of Cyclosporine Demonstrated in Phase 3 CIRCUS Clinical Trial
In the phase 3 CIRCUS trial, the immunosuppressant drug cyclosporine held no benefits for patients who sustained ST-segment elevation myocardial infarctions.
- Loading...
Loading...
Next post in ESC Meeting Highlights
Loading... 
Loading...